FLT3 and acute myeloid leukemia: To investigate the effects of DM formulations, AML FLT3-positive cells, leukemic stem cell-like KG-1a cells, and leukemic EoL-1 cells were used to evaluate the cytotoxic effects of Dox solution, DM, and DM-conjugated peptides.